Annovis Bio, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Annovis Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Annovis Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.39M, a 70.5% increase year-over-year.
  • Annovis Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$30.4M, a 28.3% increase year-over-year.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2023 was -$45M, a 76.5% decline from 2022.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2022 was -$25.5M, a 75.5% decline from 2021.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2021 was -$14.5M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$45M -$19.5M -76.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$25.5M -$11M -75.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$14.5M -$7.9M -119% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$6.64M -$5.03M -314% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 -$1.61M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.